These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 16941655)
1. CHMP2B mutations are not a cause of dementia in Dutch patients with familial and sporadic frontotemporal dementia. Rizzu P; van Mil SE; Anar B; Rosso SM; Donker Kaat L; Heutink P; van Swieten JC Am J Med Genet B Neuropsychiatr Genet; 2006 Dec; 141B(8):944-6. PubMed ID: 16941655 [TBL] [Abstract][Full Text] [Related]
3. CHMP2B mutations are not a common cause of frontotemporal lobar degeneration. Cannon A; Baker M; Boeve B; Josephs K; Knopman D; Petersen R; Parisi J; Dickison D; Adamson J; Snowden J; Neary D; Mann D; Hutton M; Pickering-Brown SM Neurosci Lett; 2006 May; 398(1-2):83-4. PubMed ID: 16431024 [TBL] [Abstract][Full Text] [Related]
4. No association of chromatin-modifying protein 2B with sporadic frontotemporal dementia. Schumacher A; Friedrich P; Diehl-Schmid J; Ibach B; Eisele T; Laws SM; Förstl H; Kurz A; Riemenschneider M Neurobiol Aging; 2007 Nov; 28(11):1789-90. PubMed ID: 16979267 [TBL] [Abstract][Full Text] [Related]
5. Frontotemporal dementia linked to chromosome 3 (FTD-3)--current concepts and the detection of a previously unknown branch of the Danish FTD-3 family. Lindquist SG; Braedgaard H; Svenstrup K; Isaacs AM; Nielsen JE; Eur J Neurol; 2008 Jul; 15(7):667-70. PubMed ID: 18484988 [TBL] [Abstract][Full Text] [Related]
6. Genetic variability in CHMP2B and frontotemporal dementia. Momeni P; Rogaeva E; Van Deerlin V; Yuan W; Grafman J; Tierney M; Huey E; Bell J; Morris CM; Kalaria RN; van Rensburg SJ; Niehaus D; Potocnik F; Kawarai T; Salehi-Rad S; Sato C; St George-Hyslop P; Hardy J Neurodegener Dis; 2006; 3(3):129-33. PubMed ID: 16954699 [TBL] [Abstract][Full Text] [Related]
7. CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro. van der Zee J; Urwin H; Engelborghs S; Bruyland M; Vandenberghe R; Dermaut B; De Pooter T; Peeters K; Santens P; De Deyn PP; Fisher EM; Collinge J; Isaacs AM; Van Broeckhoven C Hum Mol Genet; 2008 Jan; 17(2):313-22. PubMed ID: 17956895 [TBL] [Abstract][Full Text] [Related]
8. Disruption of endocytic trafficking in frontotemporal dementia with CHMP2B mutations. Urwin H; Authier A; Nielsen JE; Metcalf D; Powell C; Froud K; Malcolm DS; Holm I; Johannsen P; Brown J; Fisher EM; van der Zee J; Bruyland M; ; Van Broeckhoven C; Collinge J; Brandner S; Futter C; Isaacs AM Hum Mol Genet; 2010 Jun; 19(11):2228-38. PubMed ID: 20223751 [TBL] [Abstract][Full Text] [Related]
16. Mutations in CHMP2B are not a cause of frontotemporal lobar degeneration in Finnish patients. Kaivorinne AL; Krüger J; Udd B; Majamaa K; Remes AM Eur J Neurol; 2010 Nov; 17(11):1393-5. PubMed ID: 20412296 [TBL] [Abstract][Full Text] [Related]
17. Frontotemporal dementia caused by CHMP2B mutation is characterised by neuronal lysosomal storage pathology. Clayton EL; Mizielinska S; Edgar JR; Nielsen TT; Marshall S; Norona FE; Robbins M; Damirji H; Holm IE; Johannsen P; Nielsen JE; Asante EA; Collinge J; ; Isaacs AM Acta Neuropathol; 2015 Oct; 130(4):511-23. PubMed ID: 26358247 [TBL] [Abstract][Full Text] [Related]
18. Absence of FUS-immunoreactive pathology in frontotemporal dementia linked to chromosome 3 (FTD-3) caused by mutation in the CHMP2B gene. Holm IE; Isaacs AM; Mackenzie IR Acta Neuropathol; 2009 Nov; 118(5):719-20. PubMed ID: 19844732 [No Abstract] [Full Text] [Related]
19. TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of ESCRT-III. Jun MH; Han JH; Lee YK; Jang DJ; Kaang BK; Lee JA Mol Brain; 2015 Dec; 8():85. PubMed ID: 26651479 [TBL] [Abstract][Full Text] [Related]
20. The molecular basis of frontotemporal dementia. Neumann M; Tolnay M; Mackenzie IR Expert Rev Mol Med; 2009 Jul; 11():e23. PubMed ID: 19638255 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]